financetom
Business
financetom
/
Business
/
Karnataka plans five-year ban on construction of multi-storeyed residential buildings in Bengaluru
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Karnataka plans five-year ban on construction of multi-storeyed residential buildings in Bengaluru
Jun 28, 2019 10:07 AM

The Karnataka government is contemplating a five-year ban on construction of multi-storeyed residential buildings in view of the acute water crisis, deputy chief minister Dr G Parameshwara said.

Speaking to reporters, he also alleged failure of the builders to provide water to those dwelling in apartments. The builders sell the apartments to families without assuring them of water availability, he said.

When the water sources go dry, the apartment dwellers depend on tankers, and the water supplied through the tankers allegedly cause water-borne and skin diseases, he said.

Due to water scarcity, deliberations were on to ban the construction of apartments in the city for the next five years, Parameshwara said. The government would soon convene a meeting of all the builders and developers to seek their opinion on the issue to take a final call, he said.

The deputy chief minister said he has directed the Bruhat Bengaluru Mahanagara Palike (BBMP) officials to make sure that the apartments have functional sewage treatment plants.

Stating that the Cauvery fifth stage water supply project was in progress, Parameshwara said it would be inadequate to meet the water requirements of the city.

Hence, officials have been directed to prepare a Detailed Project Report (DPR) to bring water from Linganamakki dam in Shivamogga district, around 400 km from Bengaluru, near coastal Karnataka.

"I have heard of opposition to this project (water from Linganamakki) too. Once the DPR is ready, we will examine the pros and cons of the project," he said.

First Published:Jun 28, 2019 7:07 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Tempus AI Insider Sold Shares Worth $13,278,632, According to a Recent SEC Filing
Feb 3, 2025
03:10 AM EST, 02/03/2025 (MT Newswires) -- Eric P Lefkofsky, 10% Owner, Director, Chief Executive Officer and Chairman, on January 29, 2025, sold 238,800 Class A common shares in Tempus AI ( TEM ) for $13,278,632. Following the Form 4 filing with the SEC, Lefkofsky has control over a total of 48,757,318 shares of the company, with 5,532,987 shares held...
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Alkermes Insider Sold Shares Worth $3,234,382, According to a Recent SEC Filing
Feb 3, 2025
03:12 AM EST, 02/03/2025 (MT Newswires) -- Craig C. Hopkinson, Executive Vice President, Research & Development, Chief Medical Officer, on January 30, 2025, sold 100,918 ordinary shares in Alkermes ( ALKS ) for $3,234,382. Following the Form 4 filing with the SEC, Hopkinson has control over a total of 44,290 shares of the company, with 44,290 shares held directly. SEC...
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Natera Insider Sold Shares Worth $2,269,928, According to a Recent SEC Filing
Feb 3, 2025
03:09 AM EST, 02/03/2025 (MT Newswires) -- Steven Leonard Chapman, Director, Chief Executive Officer and President, on January 29, 2025, sold 13,685 common shares in Natera ( NTRA ) for $2,269,928. Following the Form 4 filing with the SEC, Chapman has control over a total of 253,944 shares of the company, with 253,944 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1604821/000141588925002621/xslF345X05/form4-01312025_090101.xml ...
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
EssilorLuxottica receives FDA clearance for its Nuance audio glasses
Feb 3, 2025
ROME (Reuters) - EssilorLuxottica said on Monday it received a green light from the U.S. Food and Drug Administration (FDA) for its over-the-counter Nuance audio glasses. Nuance - which pairs hearing solutions with prescription glasses - will be available in the U.S. and in Italy in the first quarter of the year and in other European countries, including France, Germany...
Copyright 2023-2025 - www.financetom.com All Rights Reserved